Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention

Doris M. Benbrook, Stan Lightfoot, James Ranger-Moore, Tongzu Liu, Shylet Chengedza, William L. Berry, Igor Dozmorov

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

An organotypic model of endometrial carcinogenesis and chemoprevention was developed in which normal endometrial organotypic cultures exposed to the carcinogen, DMBA (7,12-dimethylbenz[a]anthracene), developed a cancerous phenotype in the absence, but not presence of subsequent treatment with a flexible heteroarotinoid (Flex-Het), called SHetA2. A discriminant function based on karyometric features of cellular nuclei and an agar clonogenic assay confirmed these histologic changes. Interpretation of microarray data using an internal standard approach identified major pathways associated with carcinogenesis and chemoprevention governed by c-myc, p53, TNFα and Jun genes. Cluster analysis of functional associations of hypervariable genes demonstrated that carcinogenesis is accompanied by a stimulating association between a module of genes that includes tumor necrosis factor α (TNFα), c-myc, and epidermal growth factor-receptor (EGF-R) and a module that includes insulin-like growth factor I-receptor (IGF-IR), p53, and Jun genes. Two secreted proteins involved in these systems, tenascin C and inhibin A, were validated at the protein level. Tenascin C is an EGF-R ligand, and therefore may contribute to the increased EGF-R involvement in carcinogenesis. The known roles of the identified molecular systems in DMBA and endometrial carcinogenesis and chemoprevention supports the validity of this model and the potential clinical utility of SHetA2 in chemoprevention.

Original languageEnglish (US)
Pages (from-to)21-42
Number of pages22
JournalGene Regulation and Systems Biology
Volume2008
Issue number2
StatePublished - 2008

Fingerprint

chemoprevention
Chemoprevention
Biological systems
Systems Analysis
Gene expression
carcinogenesis
gene expression
Carcinogenesis
Genes
Gene Expression
Epidermal Growth Factor Receptor
jun Genes
gene
Tenascin
9,10-Dimethyl-1,2-benzanthracene
tumor
tumor necrosis factors
Proteins
Carcinogens
Tumor Necrosis Factor-alpha

Keywords

  • Carcinogenesis
  • Chemoprevention
  • Endometrial cancer
  • Heteroarotinoid
  • Karyometric analysis
  • Microarrays

ASJC Scopus subject areas

  • Genetics
  • Ecology, Evolution, Behavior and Systematics
  • Computer Science Applications
  • Molecular Biology

Cite this

Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention. / Benbrook, Doris M.; Lightfoot, Stan; Ranger-Moore, James; Liu, Tongzu; Chengedza, Shylet; Berry, William L.; Dozmorov, Igor.

In: Gene Regulation and Systems Biology, Vol. 2008, No. 2, 2008, p. 21-42.

Research output: Contribution to journalArticle

Benbrook, DM, Lightfoot, S, Ranger-Moore, J, Liu, T, Chengedza, S, Berry, WL & Dozmorov, I 2008, 'Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention', Gene Regulation and Systems Biology, vol. 2008, no. 2, pp. 21-42.
Benbrook, Doris M. ; Lightfoot, Stan ; Ranger-Moore, James ; Liu, Tongzu ; Chengedza, Shylet ; Berry, William L. ; Dozmorov, Igor. / Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention. In: Gene Regulation and Systems Biology. 2008 ; Vol. 2008, No. 2. pp. 21-42.
@article{c2ac0d6533c14053907fd785b60b9990,
title = "Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention",
abstract = "An organotypic model of endometrial carcinogenesis and chemoprevention was developed in which normal endometrial organotypic cultures exposed to the carcinogen, DMBA (7,12-dimethylbenz[a]anthracene), developed a cancerous phenotype in the absence, but not presence of subsequent treatment with a flexible heteroarotinoid (Flex-Het), called SHetA2. A discriminant function based on karyometric features of cellular nuclei and an agar clonogenic assay confirmed these histologic changes. Interpretation of microarray data using an internal standard approach identified major pathways associated with carcinogenesis and chemoprevention governed by c-myc, p53, TNFα and Jun genes. Cluster analysis of functional associations of hypervariable genes demonstrated that carcinogenesis is accompanied by a stimulating association between a module of genes that includes tumor necrosis factor α (TNFα), c-myc, and epidermal growth factor-receptor (EGF-R) and a module that includes insulin-like growth factor I-receptor (IGF-IR), p53, and Jun genes. Two secreted proteins involved in these systems, tenascin C and inhibin A, were validated at the protein level. Tenascin C is an EGF-R ligand, and therefore may contribute to the increased EGF-R involvement in carcinogenesis. The known roles of the identified molecular systems in DMBA and endometrial carcinogenesis and chemoprevention supports the validity of this model and the potential clinical utility of SHetA2 in chemoprevention.",
keywords = "Carcinogenesis, Chemoprevention, Endometrial cancer, Heteroarotinoid, Karyometric analysis, Microarrays",
author = "Benbrook, {Doris M.} and Stan Lightfoot and James Ranger-Moore and Tongzu Liu and Shylet Chengedza and Berry, {William L.} and Igor Dozmorov",
year = "2008",
language = "English (US)",
volume = "2008",
pages = "21--42",
journal = "Gene Regulation and Systems Biology",
issn = "1177-6250",
publisher = "Libertas Academica Ltd.",
number = "2",

}

TY - JOUR

T1 - Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention

AU - Benbrook, Doris M.

AU - Lightfoot, Stan

AU - Ranger-Moore, James

AU - Liu, Tongzu

AU - Chengedza, Shylet

AU - Berry, William L.

AU - Dozmorov, Igor

PY - 2008

Y1 - 2008

N2 - An organotypic model of endometrial carcinogenesis and chemoprevention was developed in which normal endometrial organotypic cultures exposed to the carcinogen, DMBA (7,12-dimethylbenz[a]anthracene), developed a cancerous phenotype in the absence, but not presence of subsequent treatment with a flexible heteroarotinoid (Flex-Het), called SHetA2. A discriminant function based on karyometric features of cellular nuclei and an agar clonogenic assay confirmed these histologic changes. Interpretation of microarray data using an internal standard approach identified major pathways associated with carcinogenesis and chemoprevention governed by c-myc, p53, TNFα and Jun genes. Cluster analysis of functional associations of hypervariable genes demonstrated that carcinogenesis is accompanied by a stimulating association between a module of genes that includes tumor necrosis factor α (TNFα), c-myc, and epidermal growth factor-receptor (EGF-R) and a module that includes insulin-like growth factor I-receptor (IGF-IR), p53, and Jun genes. Two secreted proteins involved in these systems, tenascin C and inhibin A, were validated at the protein level. Tenascin C is an EGF-R ligand, and therefore may contribute to the increased EGF-R involvement in carcinogenesis. The known roles of the identified molecular systems in DMBA and endometrial carcinogenesis and chemoprevention supports the validity of this model and the potential clinical utility of SHetA2 in chemoprevention.

AB - An organotypic model of endometrial carcinogenesis and chemoprevention was developed in which normal endometrial organotypic cultures exposed to the carcinogen, DMBA (7,12-dimethylbenz[a]anthracene), developed a cancerous phenotype in the absence, but not presence of subsequent treatment with a flexible heteroarotinoid (Flex-Het), called SHetA2. A discriminant function based on karyometric features of cellular nuclei and an agar clonogenic assay confirmed these histologic changes. Interpretation of microarray data using an internal standard approach identified major pathways associated with carcinogenesis and chemoprevention governed by c-myc, p53, TNFα and Jun genes. Cluster analysis of functional associations of hypervariable genes demonstrated that carcinogenesis is accompanied by a stimulating association between a module of genes that includes tumor necrosis factor α (TNFα), c-myc, and epidermal growth factor-receptor (EGF-R) and a module that includes insulin-like growth factor I-receptor (IGF-IR), p53, and Jun genes. Two secreted proteins involved in these systems, tenascin C and inhibin A, were validated at the protein level. Tenascin C is an EGF-R ligand, and therefore may contribute to the increased EGF-R involvement in carcinogenesis. The known roles of the identified molecular systems in DMBA and endometrial carcinogenesis and chemoprevention supports the validity of this model and the potential clinical utility of SHetA2 in chemoprevention.

KW - Carcinogenesis

KW - Chemoprevention

KW - Endometrial cancer

KW - Heteroarotinoid

KW - Karyometric analysis

KW - Microarrays

UR - http://www.scopus.com/inward/record.url?scp=66849092433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66849092433&partnerID=8YFLogxK

M3 - Article

VL - 2008

SP - 21

EP - 42

JO - Gene Regulation and Systems Biology

JF - Gene Regulation and Systems Biology

SN - 1177-6250

IS - 2

ER -